copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Liquidia Corporation | Corporate Website Elevating standards, instilling hope At Liquidia, we are dedicated to developing best-in-class therapies for rare cardiopulmonary diseases like pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD) to help patients breathe easier and live longer
Investors | Liquidia Corporation Explore Liquidia Corporation's investor resources, financial updates, and corporate information for insights into their innovative therapies and business strategies
Press releases | Liquidia Corporation MORRISVILLE, N C , May 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the company’s Chief Executive Officer Dr Roger Jeffs , Chief Financial Officer and Chief Operating Officer Michael Kaseta , and Chief Business Officer Jason Adair will be providing an
Technology | Liquidia Corporation Uniform size and shape The benefits of uniformly shaped and sized drug particles for inhaled delivery: Targeted delivery to the site of the disease 1 Drug particles <2 μm have greater likelihood for lower airway deposition and reduced chance of sedimenting in the upper respiratory tract 2; PRINT drug particles are uniform in size and shape, and engineered for enhanced aerosolization for
Liquidia Corporation to Report First Quarter 2025 Financial Results on . . . MORRISVILLE, N C , May 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, announced today that it will report its first quarter 2025 financial results on Thursday, May 8, 2025 The company will host a webcast at 8:30 a m Eastern Time to discuss its financial results and
Rajeev Saggar, | Management | Liquidia Corporation Rajeev Saggar, M D joined Liquidia in 2022 where he serves as the company’s Chief Medical Officer He brings more than 20 years of experience as a practicing pulmonologist to his role at Liquidia where he oversees all aspects of research, clinical development, medical affairs and regulatory affairs